Electrophysiology

The cardiac subspecialty of electrophysiology (EP) diagnoses and treats arrhythmias. This includes use of pacemakers to treat bradycardia, implantable cardioverter defibrillators (ICD) for tachycardia, heart failure and patients at risk of sudden cardiac arrest, and cardiac ablation treatments to treat heart rhythm disorders.

Money dollar investments

Catheter ablation a cost-effective option for HF patients with AFib

Researchers shared their full analysis in the Journal of the American Heart Association.

July 20, 2021
ECG rhythm strip from a 6-lead ECG

Yes, Apple’s iPhone can interfere with implantable cardiac devices—here’s what you should know

This issue “has the potential to inhibit lifesaving therapies,” according to a new analysis in the Journal of the American Heart Association.

June 2, 2021

Catheter ablation tops medication alone for treating AFib—but the risk of complications remains

Catheter ablation is associated with better outcomes for AFib patients, researchers noted, but beginning treatment with just antiarrhythmic medications may be the most practical option. 

April 29, 2021
COVID-19 coronavirus burnout depression pandemic

10 helpful tips for heart rhythm patients as the COVID-19 pandemic continues

The new analysis, published in Circulation: Arrhythmia and Electrophysiology, was designed to help patients stay informed and avoid unnecessary stress during this challenging time. 

December 18, 2020

Why early rhythm control therapy is so important for atrial fibrillation patients

The research team's findings were presented at ESC Congress 2020 and published in the New England Journal of Medicine.

August 31, 2020

SCAI shares thorough guidance on out-of-hospital cardiac arrest

The Society of Cardiovascular Angiography and Interventions (SCAI) has shared a new guidance detailing the management of patients with out-of-hospital cardiac arrest (OHCA).

May 15, 2020
heart.png

‘Potentially everything we’ve hoped for’: Pulsed field ablation used for 1st time in U.S.

Pulsed field ablation technology has been used to treat atrial fibrillation for the first time in the U.S.

February 27, 2020

Orchestra BioMed earns CE mark for BackBeat cardiac neuromodulation therapy

Orchestra BioMed, Inc., on Sept. 4 announced it received CE mark approval for its Moderato implantable pulse generation system, which delivers the company’s trademarked cardiac neuromodulation therapy to patients while simultaneously acting as a pacemaker.

September 5, 2019

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Trimed Popup
Trimed Popup